13th International Paul-Ehrlich-Seminar

Allergen Products for Diagnosis and Therapy:
Regulation and Science

The International Paul-Ehrlich-Seminar has been an expert forum for about 30 years, to discuss between regulators, scientists, and industry standardization and regulatory issues related to diagnostic and therapeutic allergen products.

Scientific Committee

Thomas Bieber, Bonn, Germany
Wesley Burks, Durham, North Carolina, USA
Fatima Ferreira, Salzburg, Austria
Anthony Frew, Brighton, United Kingdom
Marcel Hoefnagel, Bilthoven, The Netherlands
Henrik Jacobi, Hørsholm, Denmark
Jörg Kleine-Tebbe, Berlin, Germany
Philippe Moingeon, Antony-Cedex, France
Carlo Pini, Rome, Italy
Calman Prussin, NIAID, Bethesda, Maryland, USA
Ronald Rabin, Rockville, Maryland, USA
Jay E. Slater, Rockville, Maryland, USA
Rudolf Valenta, Vienna, Austria
Ronald van Ree, Amsterdam, The Netherlands
Stefan Vieths, Langen, Germany

Seminar Venue

Hyatt Regency Washington on Capitol Hill
400 New Jersey Ave, NW
Washington DC, 20001, USA

Program Chairpersons

Stefan Vieths, Paul-Ehrlich-Institut, Langen, Germany
Jay E. Slater, U.S. Food and Drug Administration, Rockville MD, USA
Ronald Rabin, U.S. Food and Drug Administration, Rockville MD, USA

Local Organization Committee

Judith Badoo, U.S. Food and Drug Administration, Rockville, MD, USA
JoAnn Boileau, DIA, Horsham, PA, USA
Constance Burnett, DIA, Horsham, PA, USA
Regina Gutberlet, Paul-Ehrlich-Institut, Langen, Germany
Leslie Haynes, U.S. Food and Drug Administration, Rockville, MD, USA
Sandra Menzies, U.S. Food and Drug Administration, Rockville, MD, USA
Ronald Rabin, U.S. Food and Drug Administration, Rockville, MD, USA
Jay E. Slater, U.S. Food and Drug Administration, Rockville, MD, USA

Main Topics

1. Legal Aspects of the Regulation of Allergen Products
2. Standardization and Characterization of Allergen Products
3. Methods in Product and Study Design of Effective Allergen Products for Therapy
4. Standardization and Characterization of Modified and Recombinant Allergen Products
5. Immunological Mechanisms of Allergy Immunotherapy
6. Immunotherapy with Purified Allergen Components
7. Extrinsic Adjuvants in the Use of Allergen Immunotherapy
8. Immunomodulatory Properties of Allergens
9. State-of-the-Art Immunotherapy in Different Allergic Diseases

Contact Information

Constance Burnett, Program Developer
Telephone 215.293.5800
Fax 215.442.6199
Email ConstanceBurnett@diahome.org

or

JoAnn Boileau, Program Manager
Telephone 215.442.6175
Fax 215.442.6199
Email JoAnn.Boileau@diahome.org

or

Regina Gutberlet
Telephone +49 6103 772401
Fax +49 6103 771258
Email regina.gutberlet@pei.de

Flyer (pdf, 162 KB)

Final Program (pdf, 1238 KB)

Further information and/or registration